Tianjin Ringpu Bio-Technology Co.,Ltd. Share Price

Stocks

300119

CNE100000TV1

Pharmaceuticals

End-of-day quote 16/10/2026 5-day change 1st Jan Change
16.05 CNY -0.31% Intraday chart for Tianjin Ringpu Bio-Technology Co.,Ltd. -4.52% -14.49%

Valuation: Tianjin Ringpu Bio-Technology Co.,Ltd.

Market Cap 7.29B 1.09B 973M 900M 820M 1.55B 104B 1.57B 10.84B 4.25B 54.14B 4.1B 4.01B 172B P/E 2026 *
17.6x
P/E 2027 * 14.6x
Enterprise Value 7.79B 1.17B 1.04B 962M 877M 1.65B 111B 1.68B 11.58B 4.54B 57.87B 4.38B 4.29B 184B EV / Sales 2026 *
2.08x
EV / Sales 2027 * 1.79x
Free-Float
51.96%
Yield 2026 *
2.14%
Yield 2027 * 3.07%
08-25 Tianjin Ringpu Bio-Technology Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2026 CI
06-09 Tianjin Ringpu Bio-Technology Co.,Ltd. signed an Equity Transfer Agreement to acquire an additional 30% stake in Tianjin Zhongrui Supply Chain Management Co., Ltd. from Ringpai National Chain Veterinary Hospital Management Co., Ltd. for CNY 65.9 million. CI
04-27 Tianjin Ringpu Bio-Technology Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2026 CI
03-30 Tianjin Ringpu Bio-Technology Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2025 CI
03-29 Tianjin Ringpu Bio-Technology Co.,Ltd. announces Annual dividend, payable on May 13, 2026 CI
03-26 Tianjin Ringpu Bio-Technology Co.,Ltd. announced that it expects to receive CNY 300 million in funding CI
11-28 Ringpu Bio-Technology Secures Registration For Feline Vaccine MT
29/10/25 Maxhealth Biotech Co. Ltd. announced that it has received CNY 400 million in funding from IDG Ventures, Shenzhen Capital Group Co., Ltd., Tianjin Ringpu Bio-Technology Co.,Ltd. CI
24/10/25 Tianjin Ringpu Bio-Technology Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2025 CI
25/08/25 Tianjin Ringpu Bio-Technology Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2025 CI
14/07/25 Ringpu Bio-Tech Forecasts Up to 70% Rise in H1 Profit MT
13/06/25 Jiangxi Twins Biotechnology Co., Ltd signed a letter of intent to acquire 67.18% stake in Hunan Sinoland Bio-Pharmacy Co., Ltd. from Tianjin Ringpu Bio-Technology Co.,Ltd. and Jingpeng Holding Group Co., Ltd for approximately CNY 115 million. CI
30/04/25 Tranche Update on Tianjin Ringpu Bio-Technology Co.,Ltd.'s Equity Buyback Plan announced on November 4, 2024. CI
1 day-0.31%
1 week-4.52%
Current month-4.24%
1 month-6.74%
3 months-2.37%
6 months-15.26%
Current year-14.49%
1 week 15.91
Extreme 15.91
16.97
1 month 15.91
Extreme 15.91
17.42
Current year 13.91
Extreme 13.91
21.51
1 year 13.91
Extreme 13.91
22.22
3 years 11.25
Extreme 11.25
28.9
5 years 11.25
Extreme 11.25
28.9
10 years 6.3
Extreme 6.3
44.41
Manager TitleAgeSince
Chief Executive Officer 53 29/03/2023
Director of Finance/CFO 51 27/04/2022
Corporate Officer/Principal 45 26/10/2020
Director TitleAgeSince
Chairman 63 11/05/2008
Director/Board Member 53 24/12/2019
Director/Board Member 51 09/01/2020
Date Insider Type Main position Quantity % Market Cap. Importance
24/05/23 Buy 3,000 0.0009%
23/05/23 Buy 1,000 0.0003%
04/09/20 Sell

Chief Executive Officer

47,300 0.0193%
Change 5-day change 1-year change 3-year change Capi.($)
-0.31%-4.52%-27.83%-9.07% 1.09B
+0.43%+6.59%+53.41%+103.85% 1,120B
+0.90%-2.25%+33.02%+62.23% 616B
+0.71%+3.24%+25.81%+93.86% 504B
-0.13%+5.98%+32.91%+50.39% 367B
+0.52%+0.24%+73.92%+40.15% 360B
-0.95%+4.70%+19.51%+43.00% 288B
-1.98%+3.73%-0.86%+13.43% 258B
-0.35%+4.25%+46.21%+50.76% 234B
-0.75%+3.32%+32.53%+97.21% 194B
Average -0.19%+3.00%+28.86%+54.58% 394.2B
Weighted average by Cap. +0.13%+3.83%+39.16%+71.41%

Financials

2026 *2027 *
Net sales 3.75B 561M 500M 463M 422M 795M 53.27B 808M 5.57B 2.18B 27.82B 2.11B 2.06B 88.63B 4.25B 637M 568M 525M 479M 902M 60.48B 917M 6.32B 2.48B 31.59B 2.39B 2.34B 101B
Net income 424M 63.46M 56.56M 52.34M 47.69M 89.87M 6.03B 91.39M 630M 247M 3.15B 238M 233M 10.03B 512M 76.72M 68.38M 63.28M 57.65M 109M 7.29B 110M 762M 299M 3.81B 288M 282M 12.12B
Net Debt 503M 75.28M 67.09M 62.09M 56.57M 107M 7.15B 108M 747M 293M 3.73B 282M 276M 11.89B 339M 50.74M 45.22M 41.85M 38.13M 71.86M 4.82B 73.07M 504M 198M 2.52B 190M 186M 8.02B
Projected Income Statement - Annual - Tianjin Ringpu Bio-Technology Co.,Ltd.
Logo Tianjin Ringpu Bio-Technology Co.,Ltd.
Tianjin Ringpu Bio-Technology Co Ltd is a China-based company serving the animal health industry. The Company's main business areas are the research and development, production and sales of veterinary biological products, veterinary pharmaceutical preparations (chemicals, traditional Chinese veterinary medicines, disinfectants, and others), veterinary raw materials, veterinary functional additives, and provision of overall prevention and control of animal diseases. The Company's products include pharmaceuticals, vaccines, disinfectants, cleaning agents, and functional additives for pigs, chickens, waterfowl, cattle, sheep and pets, and others.
Employees
2,803
Date Price Change Volume
16/10/26 CN¥16.05 -0.31% 3,817,219
15/10/26 CN¥16.10 -2.31% 3,647,800
14/10/26 CN¥16.48 +1.42% 3,107,900
13/10/26 CN¥16.25 -1.34% 3,134,900
12/10/26 CN¥16.47 -2.02% 2,668,200
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - Tianjin Ringpu Bio-Technology Co.,Ltd.
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
16.05CNY
Average target price
21.45CNY
Spread / Average Target
+33.62%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Tianjin Ringpu Bio-Technology Co.,Ltd.
  1. Stock Market
  2. Stocks
  3. 300119 Stock